Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology

What Do CSF and Spinal Tap Results Show for SREAT?

At a Glance

In SREAT, a spinal tap may show high protein or mild inflammation, but results can be normal. No single spinal fluid finding confirms SREAT, so doctors use the test mainly to look for infections and other autoimmune brain diseases alongside symptoms, scans, and blood tests.

A lumbar puncture (spinal tap) is an important step in evaluating suspected Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT), also known as Hashimoto’s encephalopathy. The test is one component of a broader evaluation. It helps doctors look for signs of inflammation in your central nervous system and is crucial for helping to evaluate other serious conditions like infections or different types of autoimmune encephalitis.

Signs of Inflammation

When doctors analyze your cerebrospinal fluid (CSF)—the clear liquid that surrounds and protects your brain and spinal cord—they are looking for specific markers that might suggest an active immune response. Because SREAT is a rare condition, there is no single spinal fluid result that confirms the diagnosis. Instead, doctors commonly look for clues such as:

  • Elevated protein: This is the most common abnormality reported in small studies of SREAT, appearing in roughly 70% to 90% of cases [1][2]. However, high protein is nonspecific and can be caused by many things, including age, other neurological conditions, or even a difficult spinal tap procedure [3].
  • White blood cells (Pleocytosis): Small case studies suggest about one-third of people with SREAT will have a mildly elevated number of white blood cells in your spinal fluid [1][3]. These are usually lymphocytes, a type of immune cell [4].
  • Oligoclonal bands: These are specific protein patterns that suggest your immune system might be producing antibodies within the central nervous system. To interpret this correctly, doctors must compare your spinal fluid to a paired blood sample. While their presence can support the idea of inflammation, they are nonspecific and do not confirm SREAT [5].

The Goal: Evaluating Other Causes

Because SREAT shares symptoms with many other neurological diseases, a major role of the spinal tap is to help determine if your symptoms are caused by something else. High thyroid antibodies in the blood are common in the general population, so doctors must ensure those antibodies aren’t just a coincidence [5][6].

To do this, your spinal fluid is tested to help evaluate:

  • Infections: Doctors will test your fluid for viruses (like herpes simplex), bacteria, and other pathogens [7][8]. While a negative result lowers the suspicion of these dangerous infections, it does not completely rule them out, especially early in an illness. Doctors will interpret these results alongside your symptoms, brain imaging, and blood tests.
  • Other Autoimmune Diseases: Sometimes, a person with high thyroid antibodies actually has a different, highly specific type of autoimmune encephalitis, such as anti-NMDA receptor encephalitis [9][10]. Targeted testing of the spinal fluid may help identify these specific brain antibodies, leading to a more precise diagnosis [11].

What if My Results Are Normal?

It is completely possible to have SREAT and have perfectly normal spinal fluid [12][13]. A normal result does not mean your symptoms aren’t real, nor does it exclude an SREAT diagnosis [14].

Instead, a normal spinal tap is helpful because it lowers the likelihood of certain infections and alternative autoimmune diseases that often cause spinal fluid abnormalities. Your care team will look at your normal spinal tap alongside your clinical symptoms, blood tests, and brain imaging to build a complete picture of your health.

Safety Note: If you or your loved one experience worsening confusion, new seizures, reduced consciousness, severe headache, or fever, seek urgent medical care. Do not wait for a spinal fluid interpretation to get help.

Common questions in this guide

What is the most common abnormal spinal tap finding in SREAT?
Higher-than-normal protein in the spinal fluid is the most commonly reported abnormality in SREAT. It is not specific to SREAT and can occur with other neurological conditions or after a difficult spinal tap, so it cannot confirm the diagnosis on its own.
Can spinal fluid be normal if I have SREAT?
Yes. People with SREAT can have normal spinal fluid, and a normal result does not rule out the condition. Doctors interpret it with symptoms, blood tests, and brain imaging.
Do white blood cells or oligoclonal bands prove SREAT?
No. A mild increase in white blood cells or the presence of oligoclonal bands may suggest inflammation, but these findings also occur in other conditions. Oligoclonal bands should be interpreted by comparing the spinal fluid with a paired blood sample.
Why is a spinal tap used to check for infections and other brain inflammation?
Spinal fluid can be tested for viruses, bacteria, and other causes of inflammation that may resemble SREAT. It can also be tested for specific antibodies associated with other autoimmune brain diseases, such as anti-NMDA receptor encephalitis. A negative infection test may lower concern but may not completely exclude an infection early in illness.
How will my doctor interpret a normal or abnormal spinal tap?
Your doctor will consider the protein level, white blood cell count, oligoclonal bands, and infection or antibody tests together rather than relying on one result. The findings are compared with your symptoms, blood thyroid antibody results, brain imaging, and the timing of your illness.

Get notified when new evidence is published on Steroid-responsive encephalopathy associated with autoimmune thyroiditis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Steroid-responsive encephalopathy in autoimmune thyroiditis (SREAT) as a differential diagnosis of Creutzfeldt-Jakob disease.

    Osmanlıoğlu Ş, Zerr I

    Neurologia i neurochirurgia polska 2023; (57(2)):198-205 doi:10.5603/PJNNS.a2023.0005.

    PMID: 36727548
  2. 2

    Hashimoto encephalopathy: A study of the clinical profile, radiological and electrophysiological correlation in a Tertiary Care Center in South India.

    Sharma PM, Javali M, Mahale R, et al.

    Journal of neurosciences in rural practice 2015; (6(3)):309-14 doi:10.4103/0976-3147.158753.

    PMID: 26167010
  3. 3

    [Hashimoto's encephalopathy].

    Arés Luque A, Ballesteros Pomar MD, Hernández Echebarría L

    Neurologia (Barcelona, Spain) 2002; (17(10)):628-32.

    PMID: 12487958
  4. 4

    Thunderclap Headache: A Primary Symptom of a Steroid-Responsive Encephalopathy with Autoimmune Thyroiditis.

    Zala N, Wirth L, Jordan B, et al.

    Case reports in neurological medicine 2021; (2021()):5517934 doi:10.1155/2021/5517934.

    PMID: 34055433
  5. 5

    Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis.

    Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al.

    Brain communications 2021; (3(2)):fcaa233 doi:10.1093/braincomms/fcaa233.

    PMID: 34061124
  6. 6

    Hashimoto encephalopathy in the 21st century.

    Mattozzi S, Sabater L, Escudero D, et al.

    Neurology 2020; (94(2)):e217-e224 doi:10.1212/WNL.0000000000008785.

    PMID: 31882532
  7. 7

    Hashimoto's Encephalopathy With Progressive Cognitive Decline: A Rare Autoimmune Disorder in Central America.

    Hong A, Santos AB, Moya Porras LF, et al.

    Cureus 2025; (17(4)):e83235 doi:10.7759/cureus.83235.

    PMID: 40453306
  8. 8

    Behind the mask of relapsing bimodal encephalitis: herpesvirus 7 and Epstein-Barr virus associated with Hashimoto's encephalopathy: a case report.

    Xing Y, Wang J, Li X, Yin X

    Frontiers in immunology 2026; (17()):1782631 doi:10.3389/fimmu.2026.1782631.

    PMID: 42292462
  9. 9

    Gerstmann's Syndrome in a Patient Double-positive for Antibodies against the N-methyl-D-aspartate Receptor and NH2-terminal of α-enolase.

    Sugiyama A, Suzuki M, Suichi T, et al.

    Internal medicine (Tokyo, Japan) 2021; (60(9)):1463-1468 doi:10.2169/internalmedicine.6344-20.

    PMID: 33229813
  10. 10

    Anti-N-methyl-D-aspartate receptor encephalitis in a young female with subclinical hypothyroidism associated with anti-thyroid peroxidase and anti-thyroglobulin antibodies: A case report.

    Khoodoruth MAS, Chut-Kai Khoodoruth WN, Alshawwaf MKM

    SAGE open medical case reports 2020; (8()):2050313X20949780 doi:10.1177/2050313X20949780.

    PMID: 32913651
  11. 11

    Hashimoto's Encephalopathy: Case Series and Literature Review.

    Chaudhuri J, Mukherjee A, Chakravarty A

    Current neurology and neuroscience reports 2023; (23(4)):167-175 doi:10.1007/s11910-023-01255-5.

    PMID: 36853554
  12. 12

    Hashimoto encephalopathy: literature review.

    Zhou JY, Xu B, Lopes J, et al.

    Acta neurologica Scandinavica 2017; (135(3)):285-290 doi:10.1111/ane.12618.

    PMID: 27324276
  13. 13

    A Case of Euthyroid Steroid-Responsive Encephalopathy With Subacute Dementia.

    John R, Datta A, Ovallath S

    Cureus 2021; (13(9)):e17689 doi:10.7759/cureus.17689.

    PMID: 34513537
  14. 14

    [A suspected case of Hashimoto encephalopathy with frequent relapses despite multiple courses of immunotherapy].

    Harada S, Inatomi Y, Nakajima M, Yonehara T

    Rinsho shinkeigaku = Clinical neurology 2020; (60(3)):200-205 doi:10.5692/clinicalneurol.cn-001361.

    PMID: 32101843

This page is for informational purposes only and does not constitute medical advice. Your neurologist and healthcare team should interpret your spinal tap results in the context of your symptoms and other tests.